These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 19841553)

  • 1. Significance and prognostic impact of co-morbidity in head and neck cancer.
    Kazi R; Nutting CM; Rhys-Evans P; Harrington KJ
    J Cancer Res Ther; 2009; 5(3):145-7. PubMed ID: 19841553
    [No Abstract]   [Full Text] [Related]  

  • 2. Importance of comorbidity in head and neck cancer.
    Piccirillo JF
    Laryngoscope; 2000 Apr; 110(4):593-602. PubMed ID: 10764003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comorbidity is a prognostic factor in elderly patients with head and neck cancer.
    Sanabria A; Carvalho AL; Vartanian JG; Magrin J; Ikeda MK; Kowalski LP
    Ann Surg Oncol; 2007 Apr; 14(4):1449-57. PubMed ID: 17235712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence and impact of comorbidity diagnosed after the onset of head and neck cancer.
    Yung KC; Piccirillo JF
    Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1045-9. PubMed ID: 18936348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential prognostic impact of comorbidity in head and neck cancer.
    Alho OP; Hannula K; Luokkala A; Teppo H; Koivunen P; Kantola S
    Head Neck; 2007 Oct; 29(10):913-8. PubMed ID: 17510970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the Washington University Head and Neck Comorbidity Index in a cohort of older patients.
    Sanabria A; Carvalho AL; Vartanian JG; Magrin J; Ikeda MK; Kowalski LP
    Arch Otolaryngol Head Neck Surg; 2008 Jun; 134(6):603-7. PubMed ID: 18559726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of comorbidity on the prognosis of squamous cell carcinoma in the head and neck].
    Stein M; Herberhold C; Walther EK; Langenberg S
    Laryngorhinootologie; 2000 Jun; 79(6):345-9. PubMed ID: 10923315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comorbidity as a major risk factor for mortality and complications in head and neck surgery.
    Ferrier MB; Spuesens EB; Le Cessie S; Baatenburg de Jong RJ
    Arch Otolaryngol Head Neck Surg; 2005 Jan; 131(1):27-32. PubMed ID: 15655181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using comorbidity indexes to predict costs for head and neck cancer.
    Hollenbeak CS; Stack BC; Daley SM; Piccirillo JF
    Arch Otolaryngol Head Neck Surg; 2007 Jan; 133(1):24-7. PubMed ID: 17224517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility study of the retrospective use of the Adult Comorbidity Evaluation index (ACE-27) in patients with cancer of the head and neck who had radiotherapy.
    Rogers SN; Aziz A; Lowe D; Husband DJ
    Br J Oral Maxillofac Surg; 2006 Aug; 44(4):283-8. PubMed ID: 16107297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring comorbidity in patients with head and neck cancer.
    Hall SF; Rochon PA; Streiner DL; Paszat LF; Groome PA; Rohland SL
    Laryngoscope; 2002 Nov; 112(11):1988-96. PubMed ID: 12439168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for survival after salvage reirradiation of head and neck cancer.
    Tanvetyanon T; Padhya T; McCaffrey J; Zhu W; Boulware D; Deconti R; Trotti A
    J Clin Oncol; 2009 Apr; 27(12):1983-91. PubMed ID: 19289616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in head and neck oncology: a critical appraisal for use in clinical practice.
    Chiesa F; Tradati N; Mauri S; Calabrese L; Grigolato R; Giugliano G; Zurrida S; Chiesa E; Squadrelli M; Viale G; Maiorano E
    Anticancer Res; 1998; 18(6B):4769-76. PubMed ID: 9891555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of human papillomavirus in the etiology of head and neck cancer.
    Tran N; Rose BR; O'Brien CJ
    Head Neck; 2007 Jan; 29(1):64-70. PubMed ID: 16823878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Coincidental squamous cell cancers of the esophagus and head and neck: risk and surveillance].
    Steinberg J; Schwertner C; de Villiers EM; Mir-Salim P; Kiesslich R; Stoelzel U; Scherübl H
    Z Gastroenterol; 2007 Aug; 45(8):710-4. PubMed ID: 17701861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbidity in patients with cancer of the head and neck: prevalence and impact on treatment and prognosis.
    Piccirillo JF; Vlahiotis A
    Curr Oncol Rep; 2006 Mar; 8(2):123-9. PubMed ID: 16507222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent changes in the epidemiology of head and neck cancer.
    Curado MP; Hashibe M
    Curr Opin Oncol; 2009 May; 21(3):194-200. PubMed ID: 19363341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry.
    Matta A; DeSouza LV; Shukla NK; Gupta SD; Ralhan R; Siu KW
    J Proteome Res; 2008 May; 7(5):2078-87. PubMed ID: 18407684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma.
    Hoersch B; Leiter U; Garbe C
    Br J Dermatol; 2006 Oct; 155(4):771-7. PubMed ID: 16965427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of participants in a free oral, head and neck cancer screening program.
    Gourin CG; Kaboli KC; Blume EJ; Nance MA; Koch WM
    Laryngoscope; 2009 Apr; 119(4):679-82. PubMed ID: 19213043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.